Log in

Relevant bibliographies by topics / Motor Neurone Disease / Journal articles

To see the other types of publications on this topic, follow the link: Motor Neurone Disease.

Journal articles on the topic 'Motor Neurone Disease'

Author: Grafiati

Published: 4 June 2021

Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Motor Neurone Disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Knight, Lisa. "Motor neurone disease." InnovAiT: Education and inspiration for general practice 13, no. 12 (November 23, 2020): 702–11. http://dx.doi.org/10.1177/1755738020958024.

Full text

Abstract:

Motor neurone disease describes a group of rare, fatal, neurodegenerative disorders. They are devastating conditions that cause the loss of upper and/or lower motor neurones, leading to a variety of progressive neurological symptoms that can develop over months to years. Due to the rarity of these conditions and the differing and often insidious symptoms there is typically a prolonged delay between presentation and diagnosis of between 15 and 18 months on average. There is often a short prognosis of 3 years, though this can vary significantly depending on the type of syndrome diagnosed. Primary care clinicians play a key role in both facilitating early diagnosis and subsequent management and co-ordination of care in the community.

APA, Harvard, Vancouver, ISO, and other styles

2

Jani, Bhautesh D. "Motor Neurone Disease." InnovAiT: Education and inspiration for general practice 4, no. 10 (May 12, 2011): 563–67. http://dx.doi.org/10.1093/innovait/inr044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Guiloff, R. "Motor Neurone Disease." Journal of Neurology, Neurosurgery & Psychiatry 51, no. 7 (July 1, 1988): 1015. http://dx.doi.org/10.1136/jnnp.51.7.1015-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Allen, C. "Motor Neurone Disease." Journal of Neurology, Neurosurgery & Psychiatry 57, no. 10 (October 1, 1994): 1300. http://dx.doi.org/10.1136/jnnp.57.10.1300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lloyd, Catherine M., and P. Nigel Leigh. "Motor Neurone Disease." Medicine 28, no. 8 (2000): 109–12. http://dx.doi.org/10.1383/medc.28.8.109.28532.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Guiloff, R. "Motor Neurone Disease." Journal of Neurology, Neurosurgery & Psychiatry 51, no. 4 (April 1, 1988): 601. http://dx.doi.org/10.1136/jnnp.51.4.601.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pall, Hardev S. "Motor neurone disease." Reviews in Clinical Gerontology 5, no. 3 (August 1995): 303–11. http://dx.doi.org/10.1017/s0959259800004342.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ng, Louisa, Paul Talman, and Fary Khan. "Motor neurone disease." International Journal of Rehabilitation Research 34, no. 2 (June 2011): 151–59. http://dx.doi.org/10.1097/mrr.0b013e328344ae1f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Skelton, Jane. "Motor neurone disease." Primary Health Care 15, no. 4 (May 2005): 27–30. http://dx.doi.org/10.7748/phc2005.05.15.4.27.c581.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Nageshwaran, S., L. M. Davies, I. Rafi, and A. Radunovi . "Motor neurone disease." BMJ 349, jul09 1 (July 9, 2014): g4052. http://dx.doi.org/10.1136/bmj.g4052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Sackett, B., and M. Sakel. "Motor neurone disease." BMJ 342, may03 1 (May 3, 2011): d1661. http://dx.doi.org/10.1136/bmj.d1661.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Shneerson, J. M. "Motor neurone disease." BMJ 313, no. 7052 (August 3, 1996): 244–45. http://dx.doi.org/10.1136/bmj.313.7052.244.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Norris, F. H. "Motor neurone disease." BMJ 304, no. 6825 (February 22, 1992): 459–60. http://dx.doi.org/10.1136/bmj.304.6825.459.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Talbot, K. "Motor neurone disease." Postgraduate Medical Journal 78, no. 923 (September 1, 2002): 513–19. http://dx.doi.org/10.1136/pmj.78.923.513.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Rafiq, Muhammad K. "Motor neurone disease." Sri Lanka Journal of Neurology 5, no. 1 (December 30, 2018): 2. http://dx.doi.org/10.4038/sljon.v5i1.59.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Winter, George. "Motor neurone disease." Journal of Prescribing Practice 5, no. 1 (January 2, 2023): 14–15. http://dx.doi.org/10.12968/jprp.2023.5.1.14.

Full text

Abstract:

George Winter looks at the current resources being dedicated to motor neurone disease, the funding problems new research is currently encountering, and the moral obligation we have to continue improving the quality-of-life for those with the disease

APA, Harvard, Vancouver, ISO, and other styles

17

Nicholson, Garth A. "Motor neurone disease and the life of motor neurones." Medical Journal of Australia 165, no. 4 (August 1996): 180–81. http://dx.doi.org/10.5694/j.1326-5377.1996.tb124918.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bansal, Amolak S., and Jacqueline A. Bansal. "Motor neurone disease and the life of motor neurones." Medical Journal of Australia 166, no. 2 (January 1997): 109. http://dx.doi.org/10.5694/j.1326-5377.1997.tb138743.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Abrahams, Sharon. "Motor Neurone Disease: Not only a disease of the motor neurones!" FPOP Bulletin: Psychology of Older People 1, no. 116 (July 2011): 16–20. http://dx.doi.org/10.53841/bpsfpop.2011.1.116.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Gent, Carol. "Understanding motor neurone disease." Nursing and Residential Care 14, no. 12 (December 2012): 646–49. http://dx.doi.org/10.12968/nrec.2012.14.12.646.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Chancellor, A. M. "Diagnosing motor neurone disease." BMJ 312, no. 7032 (March 16, 1996): 650–51. http://dx.doi.org/10.1136/bmj.312.7032.650.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Brewah, Helen, Kevin Borrett, Nuno Tavares, and Nikki Jarrett. "Perceptions of people with motor neurone disease, families and HSCPs: a literature review." British Journal of Community Nursing 27, no. 4 (April 2, 2022): 188–98. http://dx.doi.org/10.12968/bjcn.2022.27.4.188.

Full text

Abstract:

Motor neurone disease or amyotrophic lateral sclerosis is a rapidly progressive terminal neurodegenerative condition caused by degeneration of the upper and lower motor neurones in the central nervous system of the brain. The effects of motor neurone disease are multifaceted, leading to many adjustments in everyday life. This literature review asked what the experiences of people living with motor neurone disease was before and during the COVID-19 pandemic and during the COVID-19 pandemic, especially in terms of their condition and the support they received from health and social care services. A key theme identified was lack of knowledge among professionals when they cared for people living with motor neurone disease and their families. This lack of knowledge often resulted in delayed diagnosis and poor standards of care. COVID-19 impacted on the care of people living with motor neurone disease and their families, and there is a paucity of evidence on how services were perceived by these groups during the COVID-19 pandemic. The experiences of people living with motor neurone disease and their families are currently missing in the literature. In conclusion, further studies are required to include care of people living with motor neurone disease and their families.

APA, Harvard, Vancouver, ISO, and other styles

23

Pinto, Wladimir B. V. R., Igor Braga Farias, Bruno de Mattos Lombardi Badia, Luiz Henrique Libardi Silva, Mario Teruo Yanagiura, Marco Antônio Troccoli Chieia, Paulo Victor Sgobbi de Souza, and Acary Souza Bulle Oliveira. "Finger extension weakness and downbeat nystagmus motor neurone disease (FEWDON-MND)." Practical Neurology 19, no. 5 (April 24, 2019): 424–26. http://dx.doi.org/10.1136/practneurol-2018-002188.

Full text

Abstract:

Atypical motor neurone disease (MND) represents a challenging and expanding group of neurodegenerative disorders involving the upper or lower motor neurones, and rarely both. Neuro-ophthalmological disturbances such as gaze-evoked downbeat nystagmus are extremely rare in the context of typical and atypical MND. Finger extension weakness and downbeat nystagmus motor neurone disease (FEWDON-MND) syndrome has been recently recognised as a distinct syndromic phenotype of MND, with a characteristic clinical picture. We describe a 63-year-old woman with long-standing lower motor neurone involvement of the upper limbs, who on examination had gaze-evoked downbeat nystagmus. After extensive negative investigation for secondary causes of MND and downbeat nystagmus, we diagnosed FEWDON-MND syndrome.

APA, Harvard, Vancouver, ISO, and other styles

24

Skelton, Jane. "Dysphagia in motor neurone disease." Nursing Standard 8, no. 37 (June 8, 1994): 57–64. http://dx.doi.org/10.7748/ns.8.37.57.s57.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Kent, Anna, and Milton Keynes. "Motor neurone disease: an overview." Nursing Standard 26, no. 46 (July 18, 2012): 48–58. http://dx.doi.org/10.7748/ns.26.46.48.s51.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Williams, Timothy L. "Motor neurone disease: diagnostic pitfalls." Clinical Medicine 13, no. 1 (February 2013): 97–100. http://dx.doi.org/10.7861/clinmedicine.13-1-97.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kent, Anna. "Motor neurone disease: an overview." Nursing Standard 26, no. 46 (July 18, 2012): 48–57. http://dx.doi.org/10.7748/ns2012.07.26.46.48.c9215.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Skelton, Jane. "Dysphagia in motor neurone disease." Nursing Standard 10, no. 33 (May 8, 1996): 49–75. http://dx.doi.org/10.7748/ns.10.33.49.s53.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Marsden, Rachael. "Motor neurone disease: an overview." Primary Health Care 21, no. 10 (December 6, 2011): 31–36. http://dx.doi.org/10.7748/phc2011.12.21.10.31.c8851.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Henderson, Robert D., Nicole Hutchinson, James A. Douglas, and Carol Douglas. "Telehealth for motor neurone disease." Medical Journal of Australia 201, no. 1 (July 2014): 31. http://dx.doi.org/10.5694/mja14.00170.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Turner, Martin R., Christina Faull, Christopher J. McDermott, Annabel H. Nickol, Jonathan Palmer, and Kevin Talbot. "Tracheostomy in motor neurone disease." Practical Neurology 19, no. 6 (July 4, 2019): 467–75. http://dx.doi.org/10.1136/practneurol-2018-002109.

Full text

Abstract:

Tracheostomy-associated ventilation for the respiratory insufficiency caused by amyotrophic lateral sclerosis (motor neurone disease (MND)) is a complex issue with practical, ethical and economic dimensions. This article considers the current prevalence of tracheostomy in MND, the evidence for its benefit both for survival and quality of life, and the practicalities of its implementation. The decision to request invasive ventilatory support is among the most challenging for those living with MND. Neurologists should be prepared to discuss this option openly and objectively: we suggest a framework for discussion, including withdrawal of therapy.

APA, Harvard, Vancouver, ISO, and other styles

32

Turner, Martin R., Ammar Al-Chalabi, Christopher E. Shaw, and P. Nigel Leigh. "Riluzole and Motor Neurone Disease." Practical Neurology 3, no. 3 (June 2003): 160–69. http://dx.doi.org/10.1046/j.1474-7766.2003.07145.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Allcroft, Peter. "Breathlessness in motor neurone disease." Current Opinion in Supportive and Palliative Care 8, no. 3 (September 2014): 213–17. http://dx.doi.org/10.1097/spc.0000000000000077.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Sandercock, J. "Riluzole for motor neurone disease." BMJ 322, no. 7297 (May 26, 2001): 1305. http://dx.doi.org/10.1136/bmj.322.7297.1305.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Bäumer, Dirk, Kevin Talbot, and Martin R. Turner. "Advances in motor neurone disease." Journal of the Royal Society of Medicine 107, no. 1 (January 2014): 14–21. http://dx.doi.org/10.1177/0141076813511451.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Vellodi, C. "Motor neurone disease: the controversy." Clinical Rehabilitation 3, no. 4 (November 1989): 313–16. http://dx.doi.org/10.1177/026921558900300410.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Cox, Diane L. "Perspectives of motor neurone disease." Clinical Rehabilitation 6, no. 4 (November 1992): 333–39. http://dx.doi.org/10.1177/026921559200600409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Barnett, D., M. Ford, and C. Leperlier. "Riluzole for motor neurone disease." BMJ 323, no. 7312 (September 8, 2001): 573. http://dx.doi.org/10.1136/bmj.323.7312.573.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Howard, R. S. "Management of motor neurone disease." Postgraduate Medical Journal 78, no. 926 (December 1, 2002): 736–41. http://dx.doi.org/10.1136/pmj.78.926.736.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Clarke, Jan. "Pain in motor neurone disease." British Journal of Neuroscience Nursing 12, no. 2 (April 2, 2016): 85–87. http://dx.doi.org/10.12968/bjnn.2016.12.2.85.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Jackson, Matthew, Graham Lennox, and James Lowe. "Motor Neurone Disease-inclusion Dementia." Neurodegeneration 5, no. 4 (December 1996): 339–50. http://dx.doi.org/10.1006/neur.1996.0046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Lomen-Hoerth, Catherine. "The Motor Neurone Disease Handbook." Muscle & Nerve 36, no. 6 (2007): 873. http://dx.doi.org/10.1002/mus.20926.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Hanajima, R., Y. Ugawa, Y. Terao, and I. Kanazawa. "Double motor cortical stimulation in motor neurone disease." Electroencephalography and Clinical Neurophysiology 95, no. 4 (October 1995): P88—P89. http://dx.doi.org/10.1016/0013-4694(95)99978-o.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Tonks, Clive. "Differential diagnosis of motor neurone disease." Clinical Medicine 10, no. 6 (December 2010): 640.1–640. http://dx.doi.org/10.7861/clinmedicine.10-6-640.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

&NA;. "Motor neurone disease - move ahead cautiously." Inpharma Weekly &NA;, no. 947 (July 1994): 5. http://dx.doi.org/10.2165/00128413-199409470-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Kiernan, Matthew C. "Motor neurone disease: a Pandora's box." Medical Journal of Australia 178, no. 7 (April 2003): 311–12. http://dx.doi.org/10.5694/j.1326-5377.2003.tb05218.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Mitchell, J. Douglas. "Motor neurone disease research in Lancashire." Morecambe Bay Medical Journal 1, no. 12 (September 1, 1993): 326–30. http://dx.doi.org/10.48037/mbmj.v1i12.1225.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Dharmadasa, Thanuja, Jakub Scaber, Evan Edmond, Rachael Marsden, Alexander Thompson, Kevin Talbot, and Martin R. Turner. "Genetic testing in motor neurone disease." Practical Neurology 22, no. 2 (January 13, 2022): 107–16. http://dx.doi.org/10.1136/practneurol-2021-002989.

Full text

Abstract:

A minority (10%–15%) of cases of amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND), are currently attributable to pathological variants in a single identifiable gene. With the emergence of new therapies targeting specific genetic subtypes of ALS, there is an increasing role for routine genetic testing for all those with a definite diagnosis. However, potential harm to both affected individuals and particularly to asymptomatic relatives can arise from the indiscriminate use of genetic screening, not least because of uncertainties around incomplete penetrance and variants of unknown significance. The most common hereditary cause of ALS, an intronic hexanucleotide repeat expansion in C9ORF72, may be associated with frontotemporal dementia independently within the same pedigree. The boundary of what constitutes a possible family history of MND has therefore extended to include dementia and associated psychiatric presentations. Notwithstanding the important role of clinical genetics specialists, all neurologists need a basic understanding of the current place of genetic testing in MND, which holds lessons for other neurological disorders.

APA, Harvard, Vancouver, ISO, and other styles

49

Kelly, Moira. "Hospice care in motor neurone disease." Nursing Standard 9, no. 9 (November 23, 1994): 30–32. http://dx.doi.org/10.7748/ns.9.9.30.s40.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Lau, Fiona S., Frank P. Brennan, and Matthew D. Gardiner. "Multidisciplinary management of motor neurone disease." Australian Journal of General Practice 47, no. 9 (September 1, 2018): 593–97. http://dx.doi.org/10.31128/ajgp-02-18-4495.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!